The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Abstract
Background— The concept that venous thromboembolism (VTE) and atherosclerosis are 2 completely distinct entities has recently been challenged because patients with VTE have more asymptomatic atherosclerosis and more cardiovascular events than control subjects. We performed a meta-analysis to assess the association between cardiovascular risk factors and VTE. Methods and Results— Medline and EMBASE databases were searched to identify studies that evaluated the prevalence of major cardiovascular risk factors in VTE patients and control subjects. Studies were selected using a priori defined criteria, and each study was reviewed by 2 authors who abstracted data on study characteristics, study quality, and outcomes. Odds ratios or weighted means and 95% confidence intervals (CIs) were then calculated and pooled using a random-effects model. Statistical heterogeneity was evaluated through the use of χ 2 and I 2 statistics. Twenty-one case-control and cohort studies with a total of 63 552 patients met the inclusion criteria. Compared with control subjects, the risk of VTE was 2.33 for obesity (95% CI, 1.68 to 3.24), 1.51 for hypertension (95% CI, 1.23 to 1.85), 1.42 for diabetes mellitus (95% CI, 1.12 to 1.77), 1.18 for smoking (95% CI, 0.95 to 1.46), and 1.16 for hypercholesterolemia (95% CI, 0.67 to 2.02). Weighted mean high-density lipoprotein cholesterol levels were significantly lower in VTE patients, whereas no difference was observed for total and low-density lipoprotein cholesterol levels. Significant heterogeneity among studies was present in all subgroups except for the diabetes mellitus subgroup. Higher-quality studies were more homogeneous, and significant associations remained unchanged. Conclusions— Cardiovascular risk factors are associated with VTE. This association is clinically relevant with respect to individual screening, risk factor modification, and primary and secondary prevention of VTE. Prospective studies should further investigate the underlying mechanisms of this relationship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The Epidemiology of Venous Thromboembolism
White, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000078468.11849.66 · Cited by 2,310
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,543
Misinterpretation and misuse of the kappa statistic
MACLURE, M., & WILLETT, W. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.161 · Cited by 808
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 700
Samama, M.-M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3415 · Cited by 695
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Self-citation2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
“29 VTE may be viewed as part of the cardiovascular disease continuum and common risk factors—such as cigarette smoking, obesity, hypercholesterolaemia, hypertension and diabetes mellitus 30–33 —are shared with arterial disease, notably atherosclerosis.”
Self-citationKonstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Self-citationA Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Risk factors for venous and arterial thrombosis.
Previtali, E., Bucciarelli, P., Passamonti, S. M., & Martinelli, I. (2011) · PubMed · doi:10.2450/2010.0066-10 · Cited by 447
Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study
Holst, A. G., Jensen, G., & Prescott, E. (2010) · Circulation · doi:10.1161/circulationaha.109.921460 · Cited by 396
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome
Nelson, S. M., Matthews, P., & Poston, L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp050 · Cited by 370
Venous thrombosis in the elderly: incidence, risk factors and risk groups
ENGBERS, M. J., VAN HYLCKAMA VLIEG, A., & ROSENDAAL, F. R. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03986.x · Cited by 362
Cardiovascular Risk Factors Associated With Venous Thromboembolism
Gregson, J., Kaptoge, S., Bolton, T., Pennells, L., Willeit, P., Burgess, S., Bell, S., Sweeting, M., Rimm, E. B., Kabrhel, C., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.4537 · Cited by 357
Hyperglycemia: a prothrombotic factor?
LEMKES, B. A., HERMANIDES, J., DEVRIES, J. H., HOLLEMAN, F., MEIJERS, J. C. M., & HOEKSTRA, J. B. L. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03910.x · Cited by 346
Obesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae508 · Cited by 313
Procoagulant Activity in Hemostasis and Thrombosis: Virchow's Triad Revisited
Wolberg, A. S., Aleman, M. M., Leiderman, K., & Machlus, K. R. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31823a088c · Cited by 312
Kappelman, M. D., Horvath-Puho, E., Sandler, R. S., Rubin, D. T., Ullman, T. A., Pedersen, L., Baron, J. A., & Sorensen, H. T. (2011) · Gut · doi:10.1136/gut.2010.228585 · Cited by 304
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278
“Sixthly, men may have a higher incidence of the metabolic syndrome or other cardiovascular risk factors, which seem to confer an increased risk of venous thromboembolism.”
BackgroundProgestin-only contraception and thromboembolism: A systematic review
Tepper, N. K., Whiteman, M. K., Marchbanks, P. A., James, A. H., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.04.014 · Cited by 272
Cerebral Venous Thrombosis Associated with COVID-19
Cavalcanti, D. D., Raz, E., Shapiro, M., Dehkharghani, S., Yaghi, S., Lillemoe, K., Nossek, E., Torres, J., Jain, R., Riina, H. A., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6644 · Cited by 259
The hematologic consequences of obesity
Purdy, J. C., & Shatzel, J. J. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13560 · Cited by 227
Obesity and venous thrombosis: a review
Allman-Farinelli, M. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1297369 · Cited by 183
Rachoń, D., & Teede, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.026 · Cited by 161
“Additionally, obesity has a significant impact on the risk of venous thromboembolism risk (Ageno et al., 2008) which can be further aggravated by the use of OCP (Martinez and Avecilla, 2007).”
BackgroundBouret, S., Levin, B. E., & Ozanne, S. E. (2015) · Physiological Reviews · doi:10.1152/physrev.00007.2014 · Cited by 157
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115
Validation of obesity‐related diagnosis codes in claims data
Suissa, K., Schneeweiss, S., Lin, K. J., Brill, G., Kim, S. C., & Patorno, E. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14512 · Cited by 89
Dennis, J., Johnson, C. Y., Adediran, A. S., de Andrade, M., Heit, J. A., Morange, P.-E., Trégouët, D.-A., & Gagnon, F. (2012) · Blood · doi:10.1182/blood-2011-10-383448 · Cited by 78
Montano, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.756633 · Cited by 70
Extensive thrombosis after COVID-19 vaccine: cause or coincidence?
Graça, L. L., Amaral, M. J., Serôdio, M., & Costa, B. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-244878 · Cited by 18
Metadata
- Authors
- Ageno, W., Becattini, C., Brighton, T., Selby, R., & Kamphuisen, P. W.
- Venue
- Circulation
- Published
- 2008-01
- Volume
- 117
- Issue
- 1
- Pages
- 93-102
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2006666326
- Cited by
- 974
- References
- 72
- FWCI
- 25.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.